Cargando…

The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus

OBJECTIVE: The rate of platelet count reduction appears to differ among different liver diseases. In the present study, we investigated the difference in the platelet counts of patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic liver disease due to hepatitis C virus (CLD-H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikarashi, Yuichi, Kodama, Kazuhisa, Taniai, Makiko, Hashimoto, Etsuko, Tokushige, Katsutoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938493/ https://www.ncbi.nlm.nih.gov/pubmed/29269684 http://dx.doi.org/10.2169/internalmedicine.9853-17

Ejemplares similares

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
por: Tokushige, Katsutoshi, et al.
Publicado: (2013)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2017)

Questionnaire survey on lifestyle of patients with nonalcoholic steatohepatitis
por: Noto, Haruka, et al.
Publicado: (2014)

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease
por: Chishima, Sayaka, et al.
Publicado: (2017)

Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality
por: Ogasawara, Yuri, et al.
Publicado: (2023)

Analysis of genetic factors associated with fatty liver disease‐related hepatocellular carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2023)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Characteristics of NAFLD Based on Hypopituitarism
por: Kodama, Kazuhisa, et al.
Publicado: (2020)

Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Successful Treatment of Ascites using a Denver(Ⓡ) Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome
por: Kogiso, Tomomi, et al.
Publicado: (2016)

Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer
por: Otsuka, Nao, et al.
Publicado: (2023)

Long‐term outcome of Wilson's disease complicated by liver disease
por: Arai, Satoko, et al.
Publicado: (2021)

Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients
por: Michalak, Agata, et al.
Publicado: (2021)

Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study
por: Kogiso, Tomomi, et al.
Publicado: (2017)

The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

Atypical Sarcoidosis Diagnosed by Massive Splenomegaly
por: Saito, Satomi, et al.
Publicado: (2019)

Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients
por: Milovanovic Alempijevic, Tamara, et al.
Publicado: (2017)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers
por: Kawaguchi, Takahisa, et al.
Publicado: (2018)

Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease
por: Zhang, Geng-lin, et al.
Publicado: (2019)

Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease
por: Garjani, Afagh, et al.
Publicado: (2015)

Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study
por: Liu, Fang, et al.
Publicado: (2018)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
por: Michalak, Agata, et al.
Publicado: (2020)

Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
por: Behari, Jaideep, et al.
Publicado: (2023)

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods
por: Yoneda, Masato, et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Long-term Follow-up of a Patient with Portal Hypertension and Hepatic Failure Due to Hepatic Hydatid Disease
por: Takenaka, Yuki, et al.
Publicado: (2021)

Bardet-Biedl Syndrome Caused by Skipping of SCLT1 Complicated by Microvesicular Steatohepatitis
por: Horiuchi, Kentaro, et al.
Publicado: (2020)

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
por: Caussy, Cyrielle, et al.
Publicado: (2019)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index
por: Tobari, Maki, et al.
Publicado: (2020)

Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease
por: Zhang, Geng-lin, et al.
Publicado: (2019)

Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis
por: Skladany, Lubomir, et al.
Publicado: (2021)

Giant Hepatic Hemangioma Causing Prolonged Fever and Indicated for Resection
por: Yoshimizu, Chihiro, et al.
Publicado: (2021)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Ratio of mean platelet volume to platelet count is a potential surrogate marker predicting liver cirrhosis
por: Iida, Hiroya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jtmi27p3ccv6dntgoc11di47pv